Virios Therapeutics Llc Stock Cash And Equivalents
| VIRIDelisted Stock | USD 3.95 0.00 0.00% |
Virios Therapeutics Llc fundamentals help investors to digest information that contributes to Virios Therapeutics' financial success or failures. It also enables traders to predict the movement of Virios Stock. The fundamental analysis module provides a way to measure Virios Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Virios Therapeutics stock.
Virios |
Virios Therapeutics Llc Company Cash And Equivalents Analysis
Virios Therapeutics' Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current Virios Therapeutics Cash And Equivalents | 7.7 M |
Most of Virios Therapeutics' fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Virios Therapeutics Llc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
CompetitionIn accordance with the recently published financial statements, Virios Therapeutics Llc has 7.7 M in Cash And Equivalents. This is 99.06% lower than that of the Biotechnology sector and 98.28% lower than that of the Health Care industry. The cash and equivalents for all United States stocks is 99.72% higher than that of the company.
Virios Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Virios Therapeutics' direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Virios Therapeutics could also be used in its relative valuation, which is a method of valuing Virios Therapeutics by comparing valuation metrics of similar companies.Virios Therapeutics is currently under evaluation in cash and equivalents category among its peers.
Virios Fundamentals
| Return On Equity | -1.2 | |||
| Return On Asset | -0.68 | |||
| Current Valuation | 1.28 M | |||
| Shares Outstanding | 1.11 M | |||
| Shares Owned By Insiders | 6.74 % | |||
| Shares Owned By Institutions | 3.60 % | |||
| Number Of Shares Shorted | 469.93 K | |||
| Price To Book | 1.37 X | |||
| EBITDA | 150.9 K | |||
| Net Income | (5.3 M) | |||
| Cash And Equivalents | 7.7 M | |||
| Cash Per Share | 0.92 X | |||
| Total Debt | 358.55 K | |||
| Current Ratio | 4.76 X | |||
| Book Value Per Share | 0.11 X | |||
| Cash Flow From Operations | (4.87 M) | |||
| Short Ratio | 0.64 X | |||
| Earnings Per Share | (5.75) X | |||
| Target Price | 3.0 | |||
| Beta | 1.58 | |||
| Market Capitalization | 172.1 K | |||
| Total Asset | 4.17 M | |||
| Retained Earnings | (61.47 M) | |||
| Working Capital | 3.81 M | |||
| Net Asset | 4.17 M |
About Virios Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Virios Therapeutics Llc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Virios Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Virios Therapeutics Llc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in Virios Stock
If you are still planning to invest in Virios Therapeutics Llc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Virios Therapeutics' history and understand the potential risks before investing.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |